Nov 10, 2024, 03:48 | Insight

Tracing 40 years of breakthroughs and challenges in ADC development

Dana-Farber’s Breast Oncology Center shared a post on X: “Don't miss this recently published Cancer…

Nov 7, 2024, 15:29 | Insight

Angelo D'Alessandro: New mechanism of protection from cuproptosis in cRCC

Angelo D'Alessandro, Professor at the University of Colorado Anschutz Medical Campus, shared on X: “Now…

Nov 5, 2024, 15:59 | Blog

Elizabeth McKenna: The November issue of Cancer Discovery is now online

Elizabeth McKenna posted on X: "I'm so excited that the November issue of Cancer Discovery…

Oct 27, 2024, 16:50 | Blog

Epigenetic hallmarks affected in human cancer, suggested by Gianluca Sbardella

Gianluca Sbardella, Professor at Università Salerno, shared a post on X: "An excellent article on…

Oct 25, 2024, 17:29 | Blog

Elizabeth McKenna: What explains the differences in cancer prevalence across multicellular species?

Elizabeth McKenna, Executive Director of Cancer Discovery at the AACR, shared on LinkedIn: "What explains…

Oct 25, 2024, 16:47 | Blog

Key milestones and insights from the evolution of antibody-drug conjugates - Zymeworks Inc.

Zymeworks Inc. shared a post on Linkedin: ''We're proud to share a recent publication in…

Oct 25, 2024, 13:16 | Insight

Elizabeth McKenna: An overview of the past 4 decades of development of ADC’s

Elizabeth McKenna, Executive Editor of Cancer Discovery at American Association for Cancer Research, shared on…

Oct 24, 2024, 12:54 | Insight

Biologic and clinical analysis of childhood gamma delta T-ALL - Cancer Discovery

Cancer Discovery shared a post on X about a recent paper published by Shunsuke Kimura…

Oct 23, 2024, 14:45 | Blog

Paolo Tarantino: How do we build a new generation of safer and more active ADCs for treating cancer

Paolo Tarantino and Raffaele Colombo shared posts on X, about recent paper published in Cancer…

Oct 22, 2024, 14:57 | Insight

Joseph Grossman: Botensilimab is effective against Tumors Poorly Responsive to Conventional Immunotherapy

Joseph Grossman, Vice President of Early Clinical Development at Agenus, shared a post on LinkedIn: "The…

Oct 18, 2024, 15:37 | Insight

Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology

On October 18, 2024, during the Global Summit and Award Ceremonies for Cancer Research and…

Oct 17, 2024, 15:16 | Insight

Manel Esteller: Bidirectional impact of epigenetics and genetics

Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, shared a post on X…

Oct 14, 2024, 13:10 | Blog

Miguel Bronchud: Astrocyte-dependent local immunosuppression in brain metastasis

Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: "Spanish National Center for Cancer…

Oct 11, 2024, 15:08 | Blog

The Evolutionary Forest of Pancreatic Cancer, suggested by Anirban Maitra

Anirban Maitra shared a post on X: "New Open Access in Cancer Discovery, Katelyn Mullen graduate…

Oct 11, 2024, 04:54 | Insight

The EACR's Highlights in Cancer Research

The European Association for Cancer Research (EACR) shared the latest highlights in recent cancer research…

Oct 8, 2024, 17:17 | Insight

Elizabeth McKenna: Cell State Heterogeneity and Intercellular Transfer in glioblastoma

Elizabeth McKenna recently shared an article by Vamsi Mangena et al. published in Cancer Discovery.…

Oct 8, 2024, 15:49 | Insight

Manel Esteller: Epigenetic Hallmarks in Cancer in Cancer Discovery

Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, shared a post on X:…

Oct 7, 2024, 09:09 | Blog

Elizabeth McKenna: The October issue of Cancer Discovery is out

Elizabeth McKenna shared a post on X: "Out today in the October issue of Cancer Discovery:…

Oct 1, 2024, 18:18 | Insight

Elizabeth McKenna: Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers

Elizabeth McKenna shared a post on X about a recent paper by Jamie Medina et…

Oct 1, 2024, 15:50 | Insight

Anirban Maitra: Do multiple tumor promoting pathways converge on a common family of kinases?

Anirban Maitra shared on X: “Provocative Cancer Discovery paper from Nabeel Bardeesy, Mass General Cancer…

Sep 30, 2024, 16:38 | Insight

New work on how DNAJB1-PRKACA fusion drives Fibrolamellar Carcinoma

Ilaria Gritti shared a post on X, by Elizabeth McKenna, about a recent paper published…

Sep 27, 2024, 14:49 | Insight

The EACR Board has selected the latest highlights in recent cancer research papers

The European Association for Cancer Research shared on X: "The EACR Board has selected the…

Sep 19, 2024, 09:23 | Insight

Jessica Lin: Preclinical development and proof-of-concept clinical activity of NVL-655

Jessica Lin shared a post on LinkedIn: "We are pleased to share this article out today…

Sep 9, 2024, 17:52 | Blog

Michael Rothenberg: A next generation BRAF Inhibitor shows promise in treatment refractory cancer patients

Michael Rothenberg, Chief Medical Officer at Insitro, shared on LinkedIn: "The Pfizer, Pfizer Boulder Research Unit,…

Sep 7, 2024, 10:15 | Insight

Leo Meriranta: KLHL6 targeting the B-cell receptor and lymphoma mutations

Leo Meriranta shared on X: “Friends! I am super-excited to share our story on KLHL6…

Sep 2, 2024, 09:01 | Insight

Mrinal Patnaik: ARNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis

Mrinal Patnaik, Physician Scientist with the Division of Hematology, Department of Internal Medicine at Mayo…

Sep 2, 2024, 07:05 | Insight

Samuel Bakhoum: The role of mitochondria and free radicals in promoting the collapse of cancer micronuclei

Samuel Bakhoum, Associate Member (Professor) in HOPP and Radiation Oncology, Memorial Sloan Kettering Cancer Center,…

Aug 29, 2024, 17:26 | Blog

Natasha Rekhtman: Chromothripsis-mediated Small Cell Lung Cancer

Natasha Rekhtman posted on X: "Hot off the press from team Memorial Sloan Kettering Cancer…

Aug 14, 2024, 18:18 | Insight

Epigenetic and Oncogenic Inhibitors target KRAS-mutant Colorectal Cancers

Elizabeth McKenna shared a post on X about a recent paper by Patrick Loi et…

Aug 10, 2024, 13:39 | Insight

Botensilimab’s effectiveness against tumours poorly responsive to conventional immunotherapy

Justin Stebbing shared a post on LinkedIn: “Congratulations to Dhan Chand and the Agenus team…

Aug 6, 2024, 11:02 | Blog

Elizabeth McKenna: The August issue of Cancer Discovery is now online

Elizabeth McKenna shared a post on X: "The August issue of Cancer Discovery is now online!…

Jul 31, 2024, 15:50 | Blog

Juan Cubillos-Ruiz: Iron chelation therapy unleashes innate immune responses that control Ovarian Cancer

Juan Cubillos-Ruiz, Associate Professor for Infection and Immunology at Well Corner Medicine, shared on X:…

Jul 31, 2024, 10:17 | Opinion

Tito Sandoval: Cubillos-Ruiz Lab's latest study about iron chelation therapy for ovarian cancer

Tito Sandoval, Senior Scientist at Washington University School of Medicine in St. Louis, shared on X…

Jul 28, 2024, 12:52 | Insight

Jaehyuk Choi: A tour-de-force cellular and transcriptional dissection of Merkel cell carcinoma

Jaehyuk Choi, Associate Professor at Northwestern University, shared a post on X about a recent…

Jul 28, 2024, 12:47 | Insight

MARK2/MARK3 Kinases Are Catalytic Co-dependencies of YAP/TAZ in Human Cancer

Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X about a recent…

Jul 23, 2024, 10:34 | Insight

The EACR's highlights in cancer research

The European Association for Cancer Research (EACR) shared on X: “The EACR's Highlights in Cancer…

Jul 20, 2024, 10:27 | Blog

Elizabeth McKenna: The SCRUM-MONSTAR Cancer-Omics Ecosystem

Elizabeth McKenna shared a post on X: ''Now online in Cancer Discovery: The SCRUM-MONSTAR Cancer-Omics…

Jul 19, 2024, 22:19 | Insight

Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!

Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…

Jul 16, 2024, 03:13 | Blog

Haniel Araujo: Efficacy of the novel RAS(ON) in KRASG12C mutant NSCLC

Haniel Araujo, Thoracic and Head and Neck Medical Oncology Fellow at MD Anderson Cancer Center, shared…

Jul 14, 2024, 15:02 | Insight

Bruno Giotti: Multiple gene programs and cellular subpopulations associated with patient prognosis in pleural mesothelioma

Bruno Giotti, Postdoctoral Researcher at Icahn School of Medicine at Mount Sinai, shared a post…

Jul 14, 2024, 04:21 | Insight

Elizabeth McKenna: 4 papers with variations on the theme of cancer cell plasticity as a mechanism of resistance to KRAS inhibition

Norbert Kraut, Global Head of Cancer Research Boehringer Ingelheim, shared a post by Elizabeth McKenna,…

Jul 11, 2024, 14:56 | Insight

Simona Cristea: The multi-facet process of resistance to KRAS inhibitors in pancreatic cancer

Simona Cristea, Head of Data Science at Hale Center for Pancreatic Cancer, shared a post by…

Jul 7, 2024, 16:08 | Insight

Tumor Microenvironment Gradients in Pleural Mesothelioma

Elizabeth McKenna shared on X: "Now online in Cancer Discovery: Single-cell View of Tumor Microenvironment Gradients…

Jul 5, 2024, 16:30 | Insight

CAR NK cells with CD28 costimulation improved cell persistence and antitumor activity

Adding CD28 costimulation to cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cells targeting…

Jul 5, 2024, 14:17 | Blog

Whijae Roh: The history of chromosomal instability in genome doubled tumors

Whijae Roh, Senior Computational Biologist at Pfizer, shared a post by Elizabeth McKenna, on X: "The history…

Jul 5, 2024, 13:43 | Insight

Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth

‘Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth.’ This paper was…

Jul 4, 2024, 14:44 | Insight

Elizabeth McKenna: The July issue of Cancer Discovery is now online

Elizabeth McKenna shared a post on LinkedIn: “The July issue of Cancer Discovery is now online!…

Jul 4, 2024, 11:09 | Insight

Impact of Antibiotic Preconditioning on Microbiome and Immunity

Anirban Maitra shared on X: "The July issue of Cancer Discovery is online! Featuring a…

Jun 30, 2024, 13:42 | Blog

Sumanta K. Pal discusses CD70-Targeted Allogeneic CAR T-Cell Therapy for ccRCC - Cancer Discovery

Cancer Discovery shared on X: "Published by a nonprofit professional society, the journal enhances knowledge…

Jun 30, 2024, 05:23 | Blog

María Mayán: How and why becoming an editor

María Mayán, Research Group Leader at CINBIO, shared on X/Twitter: . "Lunch session with editors:…

Jun 28, 2024, 06:45 | Positive

Patrick Hwu: Moffitt Cancer Center is at the forefront of cancer discovery

Patrick Hwu shared on X: "Bioengineering is vital to making strides in cancer discovery, and…

Jun 25, 2024, 12:52 | Blog

Tali Lev: Excited to attend the ⁦Metastasis Research Society 20th Biennial meeting

Tali Lev, Senior Editor at Cancer Discovery, made the following post on X: . "Hi from…

Jun 25, 2024, 12:48 | Blog

Engaging with the community at the forefront of cancer science and medicine - Cancer Discovery

Cancer Discovery shared on X: . “Engaging with the community at the forefront of cancer…

Jun 23, 2024, 13:22 | Insight

Katy Rezvani: Exciting research on CD70-targeting CAR NK cells

Katy Rezvani shared Elizabeth McKenna's post on X, adding: "Many congratulations to our Dr. Sunil…

Jun 18, 2024, 14:39 | Insight

Personalised support from experienced in-house editors - AACR Journals

Elizabeth McKenna shared a post by AACR Journals on LinkedIn, adding: “Reach out to the Cancer…

Jun 9, 2024, 06:40 | Insight

W. Gregory Sawyer: Engineering Cancers End

W. Gregory Sawyer, Moffitt Cancer Center Chief BioEngineering Officer, shared on X: “Engineering Cancers End.…

May 30, 2024, 06:33 | Career

Bailee Sliker: I start a new chapter as an Oncology Scientist/Medical Writer at NCCN

Bailee Sliker, Oncology Scientist/Medical Writer at the National Comprehensive Cancer Network (NCCN), shared on X:…

May 4, 2024, 16:54 | Insight

Elizabeth McKenna: The May issue of Cancer Discovery

Elizabeth McKenna shared on LinkedIn: "The May issue of Cancer Discovery is now online! The…

May 4, 2024, 10:27 | Insight

Paolo Tarantino: HER2 is about to change again

Paolo Tarantino shared a previous post of him on X and added: "HER2 is about…

May 2, 2024, 23:03 | Career

Steven Kridel: I’m starting a new position as Chair of Department of Cancer Biology at Wake Forest University School of Medicine!

Steven Kridel, Chair, Department of Cancer Biology at Wake Forest University School of Medicine, made…

May 1, 2024, 11:57 | Blog

Direna Alonso-Curbelo receives Cancer Discovery Early Career Award

Cancer Discovery shared on X/Twitter: "Congratulations, Direna Alonso-Curbelo, on the inaugural Cancer Discovery Early Career Award!…

Apr 20, 2024, 06:57 | Insight

Read an In Focus article by Kimryn Rathmell from the latest issue - Cancer Discovery

Cancer Discovery shared a post on X: “Read an In Focus article by Kimryn Rathmell…

Apr 17, 2024, 00:52 | Insight

UHN Research - Can a blood sample be used to predict patient outcomes to cancer immunotherapy drug pembrolizumab?

UHN Research shared on their LinkedIn: "Can a blood sample be used to predict patient…

Apr 14, 2024, 14:08 | Blog

Danielle Carnival: About Biden Cancer Moonshot progress and global commitment in Cancer Discovery

Danielle Carnival, Deputy Assistant to President Biden for the Cancer Moonshot, shared on X/Twitter: "At the…

Apr 14, 2024, 06:54 | Opinion

Kimryn Rathmell: The National Cancer Plan is meant to drive innovation in cancer research

Kimryn Rathmell, Director of the National Cancer Institute, shared on X/Twitter: "The National Cancer Plan…

Apr 11, 2024, 17:38 | Insight

Vivek Subbiah: Thrilled to be featured in AACR’s special issue of Cancer Discovery

Vivek Subbiah shared a post on X: “Thrilled to be featured in American Association for…

Apr 11, 2024, 15:23 | Drugs

Piotr Wysocki: Adagrasib and cetuximab in KRAS G12C-mutated colorectal cancer is a safe and active

Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…

Apr 11, 2024, 12:10 | Blog

CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery

Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…

Apr 11, 2024, 06:46 | Opinion

Maria Natalia Gandur Quiroga: The Hallmarks of Precancer

Maria Natalia Gandur Quiroga shared a post on X: "The Hallmarks of Precancer. AACR Journals,…

Apr 10, 2024, 09:09 | Blog

Vivek Subbiah: Super delighted to meet the amazing Elizabeth McKenna, Executive Editor of Cancer Discovery

Vivek Subbiah shared on X/Twitter: "Super delighted to meet the amazing Elizabeth McKenna, Executive Editor…

Apr 8, 2024, 22:24 | Insight

NSCLC's Immune Landscape: A Comprehensive Study of the Tumor Microenvironment

A recent study, “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical…

Apr 8, 2024, 15:43 | Blog

Luis Diaz: The most recent issue of Cancer Discovery features our prescient commentaries about the future of cancer research

Luis Diaz, Head of Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center,…

Apr 7, 2024, 23:28 | Insight

Biagio Ricciuti: MET kinase domain mutations as novel & targetable alterations in NSCLC and other cancer types

Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X: "Our collaborative effort to…

Apr 6, 2024, 14:56 | Insight

Kimryn Rathmell: My Cancer Discovery commentary for a new perspective on the National Cancer Plan

Kimryn Rathmell, Director of the National Cancer Institute, recently shared on X: "Ready for AACR24?…

Apr 6, 2024, 12:55 | Societies

Productive Peer Review: Improving Science while Avoiding Pitfalls session at AACR24

The American Association for Cancer Research (AACR) shared a post on X/Twitter: "Productive Peer Review:…

Apr 6, 2024, 08:34 | Opinion

Kimryn Rathmell: My Cancer Discovery commentary for a new perspective on the National Cancer Plan

Kimryn Rathmell, Director of NCI, shared on X/Twitter: "Ready for AACR24? Before we hit the…

Mar 20, 2024, 23:02 | Blog

Attending the NIH-CZI Junior Investigators Atlas Builders Meeting? - Cancer Discovery

Cancer Discovery made the following post on X: "Are you attending the NIH-CZI Junior Investigators…

Mar 8, 2024, 19:03 | Insight

Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter: "I am excited to…

Feb 27, 2024, 19:29 | Blog

Eric Stutheit-Zhao: A blood sample can track immunotherapy response

Eric Stutheit-Zhao, Resident Doctor at Department of Radiation Oncology, University of Toronto, shared a post…

Feb 24, 2024, 16:50 | Blog

Toni Choueiri: New insights from the JAVELIN Renal 101 trial in RCC in Cancer Discovery

Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center for…

Feb 1, 2024, 13:52 | Blog

Yuki Saito: A pan-cancer landscape of driver alterations and their clinical actionability in Japanese patients

Yuki Saito, Postdoctoral researcher at Keisuke Kataoka Laboratory, shared a post by Keisuke Kataoka Laboratory…

Jan 18, 2024, 16:08 | Insight

Yüksel Ürün: Exciting news for cancer patients and researchers alike!

Yüksel Ürün, Professor at the Department of Medical Oncology at the Ankara University School of…

Dec 24, 2023, 18:34 | Insight

Norbert Kraut: A must-read Precision Oncology: 2023 in Review

Norbert Kraut, Global Head of Cancer Research, Boehringer Ingelheim, shared on X/Twitter: "2023 has been…

Dec 16, 2023, 11:12 | Insight

Ron DePinho: December issue of Cancer Discovery is now online

Ron DePinho, Professor and Past President MD Anderson Cancer Center, shared on X: "December issue…

Dec 6, 2023, 15:38 | Insight

Vivek Subbiah: Terrific review out in Cancer Discovery

Vivek Subbiah shared on LinkedIn: "Terrific review out in Cancer Discovery. Tumor evolution is fueled…

Dec 6, 2023, 11:48 | Opinion

Ruben Mesa: An inspiring read by our Advocate Health CEO Eugene A. Woods

Ruben Mesa, President at Atrium Health Levine Cancer, shared on LinkedIn: "Just finished this inspiring…

Dec 5, 2023, 19:35 | Blog

Vivek Subbiah: Cancer Evolution: A Multifaceted Affair! An amazing review

Vivek Subbiah made the following post on Twitter: "Cancer Evolution: A Multifaceted Affair! An amazing…

Oct 14, 2023, 16:21 | Positive

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 8

Once again, it's Saturday, and we continue OncoDaily’s series, '100 Influential Women in Oncology: Key…

Sep 28, 2023, 19:04 | Blog

Elizabeth McKenna: Cancer Discovery is issuing a call for short commentaries that challenge existing paradigms or shed new light on arising issues or emerging topics in the field.

Sep 5, 2023, 17:18 | Insight

Vivek Subbiah: Give the right drug, to the right patient, at the right time in every country, to think globally and act locally.

Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on LinkedIn:…

Sep 2, 2023, 19:03 | Insight

Sumanta K. Pal: We are soon to begin a trial of camu camu with IO in kidney cancer, inspired by Bertrand Routy’s excellent paper in Cancer Discovery, at City of Hope.

Quoting Sumanta K. Pal, the co-director of City of Hope's Kidney Cancer Program, on X/Twitter:…

Aug 11, 2023, 19:30 | Drugs

Vivek Subbiah: Pralsetinib has received FULL FDA approval

Exciting News for RET+ patients! Pralsetinib has received FULL FDA approval! From treating the 1st…